Two Genentech vets reunite at Immune-Onc to help steer its $33M drive to the clinic

news
Written By Guest User
Guest User
Previous

Researchers find potential new way to target lethal form of leukemia
Next

What You Need to Know About Immune-Onc Therapeutics